Rohto Pharmaceutical Co.,Ltd.
4527.T
Get informed when a big investor buys or sells
+ FollowMarket Cap$608.52B
Close$
Share Statistics
| Market cap | $608.52 Billion |
|---|---|
| Enterprise Value | $582.04 Billion |
| Dividend Yield | $46.00 (1.86%) |
| Earnings per Share | $151.56 |
| Beta | -0.43 |
| Outstanding Shares | 225,964,000 |
Return
| Return on Equity | 10.80% |
|---|---|
| Return on Assets | 6.86% |
| Return on Invested Capital | 11.38% |
Valuation & Multiples
| P/E Ratio | 18.37 |
|---|---|
| PEG | -173.5 |
| Price to Sales | 1.72 |
| Price to Book Ratio | 1.87 |
| Enterprise Value to Revenue | 1.64 |
| Enterprise Value to EBIT | 13.6 |
| Enterprise Value to Net Income | 17 |
| Total Debt to Enterprise | 0.1 |
| Debt to Equity | 0.19 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 6, 2026
EPS Estimate
$38.77
Average shareholder expectationRevenue Estimate
$87.05 B
Average shareholder expectationNext Earnings Call
Expected Date
November 12, 2026
EPS Estimate
$32.77
Average shareholder expectationRevenue Estimate
$88.79 B
Average shareholder expectationInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Rohto Pharmaceutical Co.,Ltd.
9,292 employees
CEO: Hidetoshi Segi Established in Osaka, Japan, in 1899, Rohto Pharmaceutical Co.,Ltd. is a global entity engaged in the development, manufacturing, and marketing of a diverse array of pharmaceutical goods, beauty products, and nutritional supplements. The...